Floaters

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

PulseMedica
PulseMedicaAB - Edmonton
2 programs
SVO-IDN/A1 trial
SVO-IDN/A1 trial
Active Trials
NCT06097897Completed91Est. Mar 2025
NCT06204848Completed44Est. Jul 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
PulseMedicaSVO-ID
PulseMedicaSVO-ID

Clinical Trials (2)

Total enrollment: 135 patients across 2 trials

Imaging of Vitreous Opacities in a Canadian Population

Start: Nov 2024Est. completion: Jul 202544 patients
N/ACompleted

Imaging of Vitreous Opacities in Human Eyes

Start: Apr 2024Est. completion: Mar 202591 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space